Biotech · Private company · Bellefonte, PA, US
Actuated Medical, Inc.
Track this companyFree. Adds Actuated Medical, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- BabyGentleStickPain From Heel SticksClinicalTrials.gov · fetched Nov 12, 2026
- BabyGentleStick™ OFFLack of Adverse EventsClinicalTrials.gov · fetched Nov 12, 2026
- BabyGentleStick™ ONLack of Adverse EventsClinicalTrials.gov · fetched Nov 12, 2026
- GripTractPolyps ColorectalClinicalTrials.gov · fetched Nov 12, 2026
- Standard Lancing DevicePain From Heel SticksClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Testing of GripTract-GI Endoscopic Tissue Manipulator for Use During Complex Endoscopic Polypectomies in the ColonNA · RECRUITING · started Jun 11, 2026ClinicalTrials.gov NCT06015607 · fetched Nov 12, 2026
- BGS Neonatal Pilot StudyNA · COMPLETED · started Nov 6, 2017ClinicalTrials.gov NCT03066895 · fetched Nov 12, 2026
- TubeClear® Evaluation in Pediatric Patients (Phase I)NA · TERMINATED · started Nov 1, 2016ClinicalTrials.gov NCT02724631 · fetched Nov 12, 2026
- Feasibility of BabyGentleStick- Adult Pilot StudyNA · COMPLETED · started Nov 1, 2016ClinicalTrials.gov NCT02947646 · fetched Nov 12, 2026
NIH awards10
- Vibration-integrated Lancing System to Reduce Stress, Pain Response, Heel Damage and Developmental Harm from Recurring Heel Sticks in NeonatesFiscal year 2026 · $1MNIH RePORTER 2R44NS155776-04 · fetched Nov 12, 2026
- Oscillated Insertion Tool for Minimally Invasive, Low-Damage, Accurate Placement of Delivery Cannula to Improve Efficacy for DREADDS Therapy in Alcohol Addiction TreatmentFiscal year 2026 · $660.9KNIH RePORTER 5R44AA030512-04 · fetched Nov 12, 2026
- Oscillated Insertion Tool for Minimally Invasive, Low-Damage, Accurate Placement of Delivery Cannula to Improve Efficacy for DREADDS Therapy in Alcohol Addiction TreatmentFiscal year 2025 · $1.4MNIH RePORTER 5R44AA030512-03 · fetched Nov 12, 2026
- TASK ORDER 04: BIOCOMPATIBILITY TESTING FOR RHAEOS. PERIOD OF PERFORMANCE: 7/14/2025 - 1/13/2026Fiscal year 2025 · $32.8KNIH RePORTER 75N95023D00022-0-759502500003-1 · fetched Nov 12, 2026
- ENDOVASCULAR HORIZONS TESTING TO5. RESEARCH AND DEVELOPMENT FOR BIOCOMPATIBILITY TESTING, ANIMAL STUDIES, AND STERILIZATION TESTING IN THE BLUEPRINT MEDTECH (BPMT) INITIATIVE. 08/18/2025 - 02/17/2026.Fiscal year 2025 · $65.7KNIH RePORTER 75N95023D00022-0-759502500004-1 · fetched Nov 12, 2026
- BIOCOMPATIBILITY TESTING FOR NEURASTASIS. RESEARCH AND DEVELOPMENT FOR BIOCOMPATIBILITY TESTING, ANIMAL STUDIES, AND STERILIZATION TESTING IN THE BLUEPRINT MEDTECH (BPMT) INITIATIVE. 8/18/25-02/17/26Fiscal year 2025 · $32.8KNIH RePORTER 75N95023D00022-0-759502500005-1 · fetched Nov 12, 2026
- Photoacoustic Tool to Improve Visualization and Success Rates in Sacral Neural Modulation Lead PlacementFiscal year 2024 · $331.4KNIH RePORTER 1R43DK139914-01 · fetched Nov 12, 2026
- Oscillated Insertion Tool for Minimally Invasive, Low-Damage, Accurate Placement of Delivery Cannula to Improve Efficacy for DREADDS Therapy in Alcohol Addiction TreatmentFiscal year 2024 · $1MNIH RePORTER 2R44AA030512-02 · fetched Nov 12, 2026
- Diversity Supplement for Development of an Oscillated Insertion tool to Eliminate Surgically Induced Neurodegeneration for Optical Neuroimaging of Cognitive Aging and DementiaFiscal year 2024 · $25KNIH RePORTER 3R43AG084801-01S1 · fetched Nov 12, 2026
- Diversity Supplement for Development of an Oscillated Insertion tool to Eliminate Surgically Induced Neurodegeneration for Optical Neuroimaging of Cognitive Aging and DementiaFiscal year 2024 · $25KNIH RePORTER 3R43AG084801-01S2 · fetched Nov 12, 2026